Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

A Novel Quadripolar Active Fixation Left-Ventricular Pacing Lead for Cardiac Resynchronization Therapy: Initial United Kingdom Experience.

Chapman M, Bates MGD, Behar JM, Williams I, Dewhurst M, Monkhouse C, Hayward C, Muthumala A, Chow A, Linker NJ, Thornley AR, Turley AJ.

JACC Clin Electrophysiol. 2019 Sep;5(9):1028-1035. doi: 10.1016/j.jacep.2019.05.005. Epub 2019 Jul 31.

PMID:
31537331
2.

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.

Sousa-Uva M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, Dunning J, Gudbjartsson T, Linker NJ, Sandoval E, Thielmann M, Jeppsson A, Landmesser U.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):5-33. doi: 10.1093/ejcts/ezx314. No abstract available.

PMID:
29029110
3.

Cardiac resynchronization therapy in coronary sinus atresia delivered using leadless endocardial pacing.

Thomas DE, Child NM, Owens WA, Linker NJ, James SA, Turley AJ.

HeartRhythm Case Rep. 2016 Jul 1;2(5):432-435. doi: 10.1016/j.hrcr.2016.06.010. eCollection 2016 Sep. No abstract available.

4.

Novel experience of laser-assisted 'inside-out' central venous access in a patient with bilateral subclavian vein occlusion requiring pacemaker implantation.

Aye T, Phan TT, Muir DF, Linker NJ, Hartley R, Turley AJ.

Europace. 2017 Oct 1;19(10):1750-1753. doi: 10.1093/europace/euw239.

PMID:
27742773
5.

Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?

Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, Triedman J, Van Hare GF, Gold MR.

Heart Rhythm. 2017 Jan;14(1):e41-e44. doi: 10.1016/j.hrthm.2016.09.012. Epub 2016 Sep 19. Review. No abstract available.

PMID:
27659101
6.

Pacemaker implantation in superior vena cava obstruction: Re-canalization, venoplasty, and stenting.

Thomas DE, Phan TT, Hartley R, Linker NJ, Muir DF, Turley AJ.

J Cardiol Cases. 2016 Apr 9;14(1):29-31. doi: 10.1016/j.jccase.2016.03.010. eCollection 2016 Jul.

7.

Cardiac resynchronization combined with coronary artery bypass grafting.

Linker NJ, Martin RI.

Eur J Cardiothorac Surg. 2016 Jul;50(1):42-3. doi: 10.1093/ejcts/ezw079. Epub 2016 Mar 16. No abstract available.

PMID:
26984990
8.

Safe use of MRI in people with cardiac implantable electronic devices.

Lowe MD, Plummer CJ, Manisty CH, Linker NJ; British Heart Rhythm Society.

Heart. 2015 Dec;101(24):1950-3. doi: 10.1136/heartjnl-2015-308495. Epub 2015 Sep 29. Review.

PMID:
26420818
9.

The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance.

Phan TT, Khan S, Mahmood MM, Mani S, Wadehra V, de Belder M, Thornley A, James S, Linker NJ, Turley AJ.

Open Heart. 2015 Apr 24;2(1):e000153. doi: 10.1136/openhrt-2014-000153. eCollection 2015.

10.

Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry.

Edvardsson N, Wolff C, Tsintzos S, Rieger G, Linker NJ.

Europace. 2015 Jul;17(7):1141-8. doi: 10.1093/europace/euu412. Epub 2015 Mar 10.

11.

Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study.

Kaye GC, Linker NJ, Marwick TH, Pollock L, Graham L, Pouliot E, Poloniecki J, Gammage M; Protect-Pace trial investigators.

Eur Heart J. 2015 Apr 7;36(14):856-62. doi: 10.1093/eurheartj/ehu304. Epub 2014 Sep 4.

PMID:
25189602
12.

Unexplained syncope: implications of age and gender on patient characteristics and evaluation, the diagnostic yield of an implantable loop recorder, and the subsequent treatment.

Edvardsson N, Garutti C, Rieger G, Linker NJ; PICTURE Study Investigators.

Clin Cardiol. 2014 Oct;37(10):618-25. doi: 10.1002/clc.22300. Epub 2014 May 28.

13.

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.

Dewhurst MJ, Linker NJ.

Arrhythm Electrophysiol Rev. 2014 May;3(1):9-14. doi: 10.15420/aer.2011.3.1.9. Epub 2014 May 30.

14.

Early versus delayed implantation of a loop recorder in patients with unexplained syncope--effects on care pathway and diagnostic yield.

Linker NJ, Voulgaraki D, Garutti C, Rieger G, Edvardsson N; PICTURE Study Investigators.

Int J Cardiol. 2013 Dec 10;170(2):146-51. doi: 10.1016/j.ijcard.2013.10.025. Epub 2013 Oct 15.

PMID:
24182906
15.

Video-assisted thoracoscopic left ventricular pacing in patients with and without previous sternotomy.

Nelson KE, Bates MG, Turley AJ, Linker NJ, Owens WA.

Ann Thorac Surg. 2013 Mar;95(3):907-13. doi: 10.1016/j.athoracsur.2012.11.022. Epub 2013 Jan 11.

PMID:
23313472
16.

Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry.

Edvardsson N, Frykman V, van Mechelen R, Mitro P, Mohii-Oskarsson A, Pasquié JL, Ramanna H, Schwertfeger F, Ventura R, Voulgaraki D, Garutti C, Stolt P, Linker NJ; PICTURE Study Investigators.

Europace. 2011 Feb;13(2):262-9. doi: 10.1093/europace/euq418. Epub 2010 Nov 19.

17.

Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial.

Kunadian B, Sutton AG, Vijayalakshmi K, Thornley AR, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA.

Am Heart J. 2007 May;153(5):763-71.

PMID:
17452151
18.

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.

Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.

Am Heart J. 2006 Apr;151(4):863.e1-6.

PMID:
16569550
19.

One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial.

Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA.

Heart. 2005 Oct;91(10):1330-7.

20.

A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.

Vijayalakshmi K, Williams D, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.

J Invasive Cardiol. 2004 Dec;16(12):707-11.

PMID:
15596875
21.

A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial.

Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA.

J Am Coll Cardiol. 2004 Jul 21;44(2):287-96.

22.

Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.

Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA.

J Invasive Cardiol. 2003 Mar;15(3):133-8.

PMID:
12612387
23.

Coexistent atrioventricular and nodoventricular pathways in a patient with hypertrophic cardiomyopathy.

Fitchet A, Linker NJ, Fitzpatrick AP.

Pacing Clin Electrophysiol. 2000 Jul;23(7):1184-6.

PMID:
10914380
24.
25.

Subpectoral implantation of a cardioverter defibrillator under local anaesthesia.

Lipscomb KJ, Linker NJ, Fitzpatrick AP.

Heart. 1998 Mar;79(3):253-5.

26.

QTc dispersion and risk of cardiac death in peripheral vascular disease. Dispersion of 60 ms1/2 is insufficient to change clinical management.

Linker NJ, Fitzpatrick AP.

BMJ. 1996 Oct 26;313(7064):1081, author reply 1082-3. No abstract available. Erratum in: BMJ 1996 Nov 30;313(7069):1405.

27.

Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing.

de Belder MA, Linker NJ, Jones S, Camm AJ, Ward DE.

BMJ. 1992 Oct 10;305(6858):861-5.

28.

Adenosine: a must for every casualty department.

Linker NJ.

Br J Hosp Med. 1992 Apr 15-May 5;47(8):565-7. No abstract available.

PMID:
1591554
30.

Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes.

Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE.

Am J Cardiol. 1992 Mar 1;69(6):634-8.

PMID:
1346947
31.

Catheter ablation by low energy DC shocks for successful management of atrial flutter.

O'Núnáin S, Linker NJ, Sneddon JF, Debbas NM, Camm AJ, Ward DE.

Br Heart J. 1992 Jan;67(1):67-71.

32.

A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.

O'Nunain S, Garratt CJ, Linker NJ, Gill J, Ward DE, Camm AJ.

Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):2028-34.

PMID:
1721219
33.

Transcoronary atrioventricular nodal modification using microvascular collagen.

Sneddon JF, Linker NJ, O'Nunain S, Simpson IA, Camm AJ, Ward DE.

Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):1976-80.

PMID:
1721210
34.

Dynamics of ventricular repolarisation in the congenital long QT syndromes.

Linker NJ, Camm AJ, Ward DE.

Br Heart J. 1991 Sep;66(3):230-7.

35.

Multivariate analysis to simplify the differential diagnosis of broad complex tachycardia.

Griffith MJ, de Belder MA, Linker NJ, Ward DE, Camm AJ.

Br Heart J. 1991 Aug;66(2):166-74.

36.

Alcohol ablation of atrioventricular conduction.

Sneddon JF, Ward DE, Simpson IA, Linker NJ, Wainwright RJ, Camm AJ.

Br Heart J. 1991 Mar;65(3):143-7.

37.

Electrophysiology of the long QT syndromes.

Linker NJ, Ward DE.

Clin Cardiol. 1990 Dec;13(12):873-6. Review. No abstract available.

38.
39.

Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.

Griffith MJ, Linker NJ, Garratt CJ, Ward DE, Camm AJ.

Lancet. 1990 Sep 15;336(8716):670-3.

PMID:
1975861
40.

Effect of activation sequence on ventricular refractoriness as determined by extrastimuli.

Linker NJ, Dancy M, Malik M, Jones S, Ward DE.

Cardiovasc Res. 1990 Aug;24(8):659-64.

PMID:
2224933
41.

Myopotential interference in unipolar rate responsive pacemakers.

Lau CP, Linker NJ, Butrous GS, Ward DE, Camm AJ.

Pacing Clin Electrophysiol. 1989 Aug;12(8):1324-30.

PMID:
2476756
42.

Drug effects on the sinus node. A clinical perspective.

Linker NJ, Camm AJ.

Cardiovasc Drugs Ther. 1988 Jul;2(2):165-70. Review.

PMID:
3154702
43.

Adenosine in the diagnosis of broad complex tachycardia.

Griffith MJ, Linker NJ, Ward DE, Camm AJ.

Lancet. 1988 Mar 26;1(8587):672-5.

PMID:
2451098
44.

Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia.

Shaw DB, Linker NJ, Heaver PA, Evans R.

Br Heart J. 1987 Dec;58(6):598-607.

Supplemental Content

Loading ...
Support Center